October 03, 2022
A Connecticut federal judge tossed a suit alleging Aetna and CVS failed to tell 401(k) plan participants about a prescription scheme probe that artificially inflated the companies' stocks because the plaintiffs failed to ask permission before filing a second amended complaint.